Home / Biotechnology / Bone Marrow Transplantation Market By Type (Allogeneic Bone Marrow Transplant, Autologous Bone Marrow Transplant), By Indication (Leukemia, Lymphoma, Myeloma and Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Bone Marrow Transplantation Market By Type (Allogeneic Bone Marrow Transplant, Autologous Bone Marrow Transplant), By Indication (Leukemia, Lymphoma, Myeloma and Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Published: Apr 2019 | Report Code: 59660-04-19

Industry Outlook

The bone marrow transplantation market is set to reach from US$ 8,356.4 Mn in 2017 to US$ 13,903.1 Mn by 2026 highlighting straightforward growth at a compound annual growth rate (CAGR) of 5.9% during the forecast period from 2018 to 2026. According to the research findings provided by Bristol-Myers Squibb Company, by 2040 there will be 1.85 million new cases of blood cancer will be reported worldwide.

Market Synopsis

Bone Marrow Transplantation Market

Get a sample copy for more information

"Lower risk of disease recurrence and significant rise in the number of healthy donors drive the allogeneic bone marrow transplant market growth"

Allogeneic bone marrow transplant are currently dominating the type segment for bone marrow transplantation market. The graft is free from contaminating tumor cells, the immunocompetent cells derived from healthy donor may produce an immune graft versus malignancy effect. Significant rise in the number of healthy donors and lower risk of disease recurrence together drive the allogeneic bone marrow transplant market. Autologous bone marrow transplant will be capturing the market in the near future owing to increasing number of stem cells banks which store healthy cells from the patients and, after conditioning treatment are introduced in the patient to produce healthy blood cells.

Bone Marrow Transplantation Market

Get a sample copy for more information

"Significant rise in the new cases of Hodgkin lymphoma patients and better survival rates post bone marrow transplantation drive the lymphoma indication market growth"

Lymphoma is currently reigning the indication segment for bone marrow transplantation market. It is of 2 types Hodgkin lymphoma and Non-Hodgkin lymphoma. National Cancer Institute (NCI) has reported 83,180 new cases of lymphoma in 2018. Significant rise in lymphoma patients and better survival rates post bone marrow transplantation drive the lymphoma indication market growth. Leukemia is the abnormal production of white blood cells in the bone marrow, National Cancer Institute (NCI) has reported 60,300 new cases of leukemia in 2018.

Bone Marrow Transplantation Market

Get a sample copy for more information

"Rising prevalence of chronic lymphocytic leukemia and presence of sophisticated healthcare infrastructure drive the market growth in North America"

In the present scenario North America with a revenue share of 38% is the clear leader in bone marrow transplantation market. The chief parameters contributing towards its market success are rising prevalence of chronic lymphocytic leukemia. According to American Cancer Society (ACS) research findings in 2019, it is estimated that approximately 20,720 new cases of chronic lymphocytic leukemia will be reported in North America. The prevalence rate is slightly more in men in comparison to women. Presence of sophisticated healthcare infrastructure further consolidates the market growth in North America region. Europe is in second position accounting for 32% market share owing to increasing number of patients suffering with multiple myeloma. As per the latest report provided by Myeloma Patients Europe (MPE) by 2025 the number of patients suffering with multiple myeloma will be around 46,000. Domicile of major players such as Lonza Group Ltd., Merck Millipore Corporation and PromoCell GmbH further bolster the market growth in Europe. Currently Asia Pacific holds 20% market share on account of proactive government policies to curb mortality rate associated with blood cancer and technological advancement in the bone marrow transplantation technique.

Bone Marrow Transplantation Market

Historical & Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The market segmentation comprises of by type, indication and geography.

ATTRIBUTE DETAILS
Research Period  2017-2027
Base Year 2018
Forecast Period  2019-2027
Historical Year  2017
Unit  USD Million
Segmentation

 By Type (2016–2026; US$ Mn)
 • Allogeneic Bone Marrow Transplant
 • Autologous Bone Marrow Transplant

 By Indication (2016–2026; US$ Mn)
 • Leukemia
 • Lymphoma
 • Myeloma
 • Others

 Geography Segment (2016–2026; US$ Mn)
 • North America (U.S., Canada)
 • Europe (U.K., Germany, Rest of Europe)
 • Asia Pacific (China, Japan, Rest of Asia Pacific)
 • Latin America (Brazil, Mexico, Rest of Latin America)
 • Middle East and Africa (GCC, Rest of MEA)

Biotechnology firms actively engaged in bone marrow transplantation procedures are AllCells LLC., Conversant Bio., Cellular Dynamics International, Gamida Cell Ltd., Hemacare Corporation, Lonza Group Ltd., Merck Millipore Corporation, Mesoblast Ltd., PromoCell GmbH and STEMCELL Technologies.

Key questions answered in this report

  • Which biopharmaceutical companies are active in the bone marrow transplantation market?
  • What will be the SWOT analysis of bone marrow transplantation market?
  • What are the prevalence rate and clinical manifestation of leukemia, lymphoma, myeloma and other blood disorders?
  • What is the global incidence rate for lymphoma and what is the survival rate post bone marrow transplantation?
  • What is the difference between allogeneic and autologous bone marrow transplantation and its suitability as per clinical manifestation of patients?
  • What will be the market size and CAGR of developing nations of Asia Pacific, MEA and Latin America region?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global BMT Market Portraiture
2.2. Global BMT Market, by Type, 2017 (US$ Mn)
2.3. Global BMT Market, by Indication, 2017 (US$ Mn)
2.4. Global BMT Market, by Geography, 2017 (US$ Mn)

Chapter 3. Bone Marrow Transplantation (BMT) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global BMT Market, by Key Players, 2017

Chapter 4. Global Bone Marrow Transplantation (BMT) Market, by Type
4.1. Overview
4.2. Allogeneic Bone Marrow Transplant
4.3. Autologous Bone Marrow Transplant

Chapter 5. Global Bone Marrow Transplantation (BMT) Market, by Indication
5.1. Overview
5.2. Leukemia
5.3. Lymphoma
5.4. Myeloma
5.5. Others

Chapter 6. Global Bone Marrow Transplantation (BMT) Market, by Geography
6.1. Overview
6.2. North America BMT Market Analysis, 2016 – 2026
6.2.1. North America BMT Market, by Type, 2016 – 2026 (US$ Mn)
6.2.2. North America BMT Market, by Indication, 2016 – 2026 (US$ Mn)
6.2.3. North America BMT Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe BMT Market Analysis, 2016 – 2026
6.3.1. Europe BMT Market, by Type, 2016 – 2026 (US$ Mn)
6.3.2. Europe BMT Market, by Indication, 2016 – 2026 (US$ Mn)
6.3.3. Europe BMT Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific BMT Market Analysis, 2016 – 2026
6.4.1. Asia Pacific BMT Market, by Type, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific BMT Market, by Indication, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific BMT Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America BMT Market Analysis, 2016 – 2026
6.5.1. Latin America BMT Market, by Type, 2016 – 2026 (US$ Mn)
6.5.2. Latin America BMT Market, by Indication, 2016 – 2026 (US$ Mn)
6.5.3. Latin America BMT Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa BMT Market Analysis, 2016 – 2026
6.6.1. MEA BMT Market, by Type, 2016 – 2026 (US$ Mn)
6.6.2. MEA BMT Market, by Indication, 2016 – 2026 (US$ Mn)
6.6.3. MEA BMT Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. AllCells LLC
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Conversant Bio
7.3. Cellular Dynamics International
7.4. Gamida Cell Ltd.
7.5. Hemacare Corporation
7.6. Lonza Group Ltd.
7.7. Merck Millipore Corporation
7.8. Mesoblast Ltd
7.9. PromoCell GmbH
7.10. STEMCELL Technologies.

* BMT - Bone Marrow Transplantation

FIG. 1 : Bone Marrow Transplantation (BMT) Market: Research Methodology
FIG. 2 : BMT: Market Segmentation
FIG. 3 : Global BMT Market, by Type, 2017 (US$ Mn)
FIG. 4 : Global BMT Market, by Indication, 2017 (US$ Mn)
FIG. 5 : Global BMT Market, by Geography, 2017 (US$ Mn)
FIG. 6 : Attractive Investment Proposition: by Geography, 2017
FIG. 7 : Competitive Analysis: Global BMT Market, by Key Players, 2017
FIG. 8 : Global Allogeneic BMT Market, 2016 – 2026 (US$ Mn)
FIG. 9 : Global Autologous BMT Market, 2016 – 2026 (US$ Mn)
FIG. 10 : Global Leukemia Market for BMT, 2016 – 2026 (US$ Mn)
FIG. 11 : Global Lymphoma Market for BMT, 2016 – 2026 (US$ Mn)
FIG. 12 : Global Myeloma Market for BMT, 2016 – 2026 (US$ Mn)
FIG. 13 : Global Other Indications Market for BMT, 2016 – 2026 (US$ Mn)
FIG. 14 : U.S. BMT Market, 2016 – 2026 (US$ Mn)
FIG. 15 : Canada BMT Market, 2016 – 2026 (US$ Mn)
FIG. 16 : U.K. BMT Market, 2016 – 2026 (US$ Mn)
FIG. 17 : Germany BMT Market, 2016 – 2026 (US$ Mn)
FIG. 18 : Rest of Europe BMT Market, 2016 – 2026 (US$ Mn)
FIG. 19 : China BMT Market, 2016 – 2026 (US$ Mn)
FIG. 20 : Japan BMT Market, 2016 – 2026 (US$ Mn)
FIG. 21 : Rest of Asia Pacific BMT Market, 2016 – 2026 (US$ Mn)
FIG. 22 : Brazil BMT Market, 2016 – 2026 (US$ Mn)
FIG. 23 : Mexico BMT Market, 2016 – 2026 (US$ Mn)
FIG. 24 : Rest of Latin America BMT Market, 2016 – 2026 (US$ Mn)
FIG. 25 : GCC BMT Market, 2016 – 2026 (US$ Mn)
FIG. 26 : Rest of MEA BMT Market, 2016 – 2026 (US$ Mn)

TABLE 1 : Global Bone Marrow Transplantation (BMT) Market Portraiture
TABLE 2 : Global BMT Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 3 : Global BMT Market , by Indication, 2016 – 2026 (US$ Mn)
TABLE 4 : Global BMT Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 : North America BMT Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 6 : North America BMT Market, by Indication, 2016 – 2026 (US$ Mn)
TABLE 7 : North America BMT Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 : Europe BMT Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 9 : Europe BMT Market, by Indication, 2016 – 2026 (US$ Mn)
TABLE 10 : Europe BMT Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 : Asia Pacific BMT Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 12 : Asia Pacific BMT Market, by Indication, 2016 – 2026 (US$ Mn)
TABLE 13 : Asia Pacific BMT Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 : Latin America BMT Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 15 : Latin America BMT Market, by Indication, 2016 – 2026 (US$ Mn)
TABLE 16 : Latin America BMT Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 : Middle East and Africa BMT Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 18 : Middle East and Africa BMT Market, by Indication, 2016 – 2026 (US$ Mn)
TABLE 19 : Middle East and Africa BMT Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 20 : AllCells LLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 : Conversant Bio: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 : Cellular Dynamics International: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 : Gamida Cell Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 : Hemacare Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 : Lonza Group Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 : Merck Millipore Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 : Mesoblast Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 : PromoCell GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 : STEMCELL Technologies: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Our Clients